Role of microRNAs in progenitor cell commitment and osteogenic differentiation in health and disease (Review)
- Authors:
- Maria Teresa Valenti
- Luca Dalle Carbonare
- Monica Mottes
-
Affiliations: Department of Medicine, Biomedicine and Movement Sciences, Biology and Genetics Section, University of Verona, Verona I‑37134, Italy, Department of Neurosciences, Biomedicine and Movement Sciences, Biology and Genetics Section, University of Verona, Verona I‑37134, Italy - Published online on: February 1, 2018 https://doi.org/10.3892/ijmm.2018.3452
- Pages: 2441-2449
This article is mentioned in:
Abstract
![]() |
![]() |
Valenti MT, Dalle Carbonare L and Mottes M: Osteogenic differentiation in healthy and pathological conditions. Int J Mol Sci. 18:E412016. View Article : Google Scholar : PubMed/NCBI | |
Idolazzi L, Fassio A, Tripi G, Braga V, Viapiana O, Adami G, Rossini M and Gatti D: Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone. Clin Rheumatol. 36:925–928. 2017. View Article : Google Scholar : PubMed/NCBI | |
Mäkitie RE, Haanpää M, Valta H, Pekkinen M, Laine CM, Lehesjoki AE, Schalin-Jäntti C and Mäkitie O: Skeletal characteristics of WNT1 osteoporosis in children and young adults. J Bone Miner Res. 31:1734–1742. 2016. View Article : Google Scholar : PubMed/NCBI | |
Papaioannou G, Mirzamohammadi F and Kobayashi T: MicroRNAs involved in bone formation. Cell Mol Life Sci. 71:4747–4761. 2014. View Article : Google Scholar : PubMed/NCBI | |
Yuan Y, Zhang L, Tong X, Zhang M, Zhao Y, Guo J, Lei L, Chen X, Tickner J, Xu J and Zou J: Mechanical stress regulates bone metabolism through MicroRNAs. J Cell Physiol. 232:1239–1245. 2017. View Article : Google Scholar | |
Ji X, Chen X and Yu X: MicroRNAs in osteoclastogenesis and function: Potential therapeutic targets for osteoporosis. Int J Mol Sci. 17:3492016. View Article : Google Scholar : PubMed/NCBI | |
Gennari L, Bianciardi S and Merlotti D: MicroRNAs in bone diseases. Osteoporos Int. 28:1191–1213. 2017. View Article : Google Scholar | |
Wu C, Tian B, Qu X, Liu F, Tang T, Qin A, Zhu Z and Dai K: MicroRNAs play a role in chondrogenesis and osteoarthritis (Review). Int J Mol Med. 34:13–23. 2014. View Article : Google Scholar : PubMed/NCBI | |
Huang C, Geng J and Jiang S: MicroRNAs in regulation of osteogenic differentiation of mesenchymal stem cells. Cell Tissue Res. 368:229–238. 2017. View Article : Google Scholar | |
Kapinas K, Kessler C, Ricks T, Gronowicz G and Delany AM: miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 285:25221–25231. 2010. View Article : Google Scholar : PubMed/NCBI | |
Gong Y, Xu F, Zhang L, Qian Y, Chen J, Huang H and Yu Y: MicroRNA expression signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells. Mol Cell Biochem. 387:227–239. 2014. View Article : Google Scholar | |
Huang J, Zhao L, Xing L and Chen D: MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells. 28:357–364. 2010. | |
Onyekwelu I, Goldring MB and Hidaka C: Chondrogenesis, joint formation, and articular cartilage regeneration. J Cell Biochem. 107:383–392. 2009. View Article : Google Scholar : PubMed/NCBI | |
Tian Y, Guo R, Shi B, Chen L, Yang L and Fu Q: MicroRNA-30a promotes chondrogenic differentiation of mesenchymal stem cells through inhibiting Delta-like 4 expression. Life Sci. 148:220–228. 2016. View Article : Google Scholar : PubMed/NCBI | |
Miyaki S, Nakasa T, Otsuki S, Grogan SP, Higashiyama R, Inoue A, Kato Y, Sato T, Lotz MK and Asahara H: MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 60:2723–2730. 2009. View Article : Google Scholar : PubMed/NCBI | |
Zhang Z, Hou C, Meng F, Zhao X, Zhang Z, Huang G, Chen W, Fu M and Liao W: MiR-455-3p regulates early chondrogenic differentiation via inhibiting Runx2. FEBS Lett. 589:3671–3678. 2015. View Article : Google Scholar : PubMed/NCBI | |
Li H, Li T, Wang S, Wei J, Fan J, Li J, Han Q, Liao L, Shao C and Zhao RC: miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res. 10:313–324. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wang J, Guan X, Guo F, Zhou J, Chang A, Sun B, Cai Y, Ma Z, Dai C, Li X and Wang B: miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6. Cell Death Dis. 10:e8452013. View Article : Google Scholar | |
Zhang JF, Fu WM, He ML, Wang H, Wang WM, Yu SC, Bian XW, Zhou J, Lin MC, Lu G, et al: MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell. 22:3955–3961. 2011. View Article : Google Scholar : PubMed/NCBI | |
Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z and Zhao RC: miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem. 114:1374–1384. 2013. View Article : Google Scholar | |
Trohatou O, Zagoura D, Bitsika V, Pappa KI, Antsaklis A, Anagnou NP and Roubelakis MG: Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med. 3:54–68. 2014. View Article : Google Scholar : | |
Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang X, Liu Y, et al: Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res. 28:559–573. 2013. View Article : Google Scholar | |
Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, Li H, Han Q and Zhao RC: Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev. 21:2531–2540. 2012. View Article : Google Scholar : PubMed/NCBI | |
Westendorf JJ: Transcriptional co-repressors of Runx2. J Cell Biochem. 98:54–64. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY, Guo LJ, Xie H, Zhou HD, Wu XP and Luo XH: A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem. 286:12328–12339. 2011. View Article : Google Scholar : PubMed/NCBI | |
Zhang JF, Fu WM, He ML, Xie WD, Lv Q, Wan G, Li G, Wang H, Lu G, Hu X, et al: MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol. 8:829–838. 2011. View Article : Google Scholar : PubMed/NCBI | |
Gámez B, Rodríguez-Carballo E, Bartrons R, Rosa JL and Ventura F: MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability. J Biol Chem. 288:14264–14275. 2013. View Article : Google Scholar : PubMed/NCBI | |
Bhushan R, Grünhagen J, Becker J, Robinson PN, Ott CE and Knaus P: miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules. Int J Biochem Cell Biol. 45:696–705. 2013. View Article : Google Scholar | |
Zheng L, Tu Q, Meng S, Zhang L, Yu L, Song J, Hu Y, Sui L, Zhang J, Dard M, et al: Runx2/DICER/miRNA pathway in regulating osteogenesis. J Cell Physiol. 232:182–191. 2017. View Article : Google Scholar | |
Li Y, Fan L, Liu S, Liu W, Zhang H, Zhou T, Wu D, Yang P, Shen L, Chen J and Jin Y: The promotion of bone regeneration through positive regulation of angiogenicosteogenic coupling using microRNA-26a. Biomaterials. 34:5048–5058. 2013. View Article : Google Scholar : PubMed/NCBI | |
Eskildsen T, Taipaleenmäki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S and Kassem M: MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA. 108:6139–6144. 2011. View Article : Google Scholar : PubMed/NCBI | |
Li E, Zhang J, Yuan T and Ma B: MiR-143 suppresses osteogenic differentiation by targeting Osterix. Mol Cell Biochem. 390:69–74. 2014. View Article : Google Scholar : PubMed/NCBI | |
Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A, Li D, Hou Z, Lv K, Kan G, et al: miR-214 targets ATF4 to inhibit bone formation. Nat Med. 19:93–100. 2013. View Article : Google Scholar | |
De-Ugarte L, Yoskovitz G, Balcells S, Güerri-Fernández R, Martinez-Diaz S, Mellibovsky L, Urreizti R, Nogués X, Grinberg D, García-Giralt N and Díez-Pérez A: MiRNA profiling of whole trabecular bone: Identification of osteoporosis-related changes in MiRNAs in human hip bones. BMC Med Genomics. 8:752015. View Article : Google Scholar : PubMed/NCBI | |
Jin HL, Kim JS, Kim YJ, Kim SJ, Broxmeyer HE and Kim KS: Dynamic expression of specific miRNAs during erythroid differentiation of human embryonic stem cells. Mol Cells. 34:177–183. 2012. View Article : Google Scholar : PubMed/NCBI | |
Gu Y, Ma L, Song L, Li X, Chen D and Bai X: miR-155 inhibits mouse osteoblast differentiation by suppressing SMAD5 expression. Biomed Res Int. 2017:18935202017. View Article : Google Scholar : PubMed/NCBI | |
Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, Kato Y, Takemoto F, Nakasa T, Yamashita S, et al: MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 24:1173–1185. 2010. View Article : Google Scholar : PubMed/NCBI | |
Papaioannou G, Inloes JB, Nakamura Y, Paltrinieri E and Kobayashi T: let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc Natl Acad Sci USA. 110:E3291–E3300. 2013. View Article : Google Scholar : PubMed/NCBI | |
Lin EA, Kong L, Bai XH, Luan Y and Liu CJ: miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem. 284:11326–11335. 2009. View Article : Google Scholar : PubMed/NCBI | |
Gu YL, Rong XX, Wen LT, Zhu GX and Qian MQ: miR-195 inhibits the proliferation and migration of chondrocytes by targeting GIT1. Mol Med Rep. 15:194–200. 2017. View Article : Google Scholar | |
Bai R, Zhao AQ, Zhao ZQ, Liu WL and Jian DM: MicroRNA-195 induced apoptosis in hypoxic chondrocytes by targeting hypoxia-inducible factor 1 alpha. Eur Rev Med Pharmacol Sci. 19:545–551. 2015.PubMed/NCBI | |
Seidl CI, Martinez-Sanchez A and Murphy CL: Derepression of MicroRNA-138 contributes to loss of the human articular chondrocyte phenotype. Arthritis Rheumatol. 68:398–409. 2016. View Article : Google Scholar | |
Yan S, Wang M, Zhao J, Zhang H, Zhou C, Jin L, Zhang Y, Qiu X, Ma B and Fan Q: MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis. Int J Mol Med. 38:201–209. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T and Zhang Y: MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol. 8:212–227. 2012. View Article : Google Scholar : PubMed/NCBI | |
Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H, Zhu W, Dai RC, Wu XP, Liao EY and Luo XH: miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res. 28:1180–1190. 2013. View Article : Google Scholar | |
Mizoguchi F, Murakami Y, Saito T, Miyasaka N and Kohsaka H: miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis Res Ther. 15:R1022013. View Article : Google Scholar : PubMed/NCBI | |
Sugatani T, Vacher J and Hruska KA: A microRNA expression signature of osteoclastogenesis. Blood. 117:3648–3657. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chen C, Cheng P, Xie H, Zhou HD, Wu XP, Liao EY and Luo XH: MiR-503 regulates osteoclastogenesis via targeting RANK. J Bone Miner Res. 29:338–347. 2014. View Article : Google Scholar | |
Qu B, Xia X, Yan M, Gong K, Deng S, Huang G, Ma Z and Pan X: miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases. Exp Cell Res. 338:89–96. 2015. View Article : Google Scholar : PubMed/NCBI | |
Guo LJ, Liao L, Yang L, Li Y and Jiang TJ: MiR-125a TNF receptor-associated factor 6 to inhibit osteoclastogenesis. Exp Cell Res. 321:142–152. 2014. View Article : Google Scholar | |
Laxman N, Rubin CJ, Mallmin H, Nilsson O, Pastinen T, Grundberg E and Kindmark A: Global miRNA expression and correlation with mRNA levels in primary human bone cells. RNA. 21:1433–1443. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kaneto CM, Lima PS, Zanette DL, Prata KL, Pina Neto JM, de Paula FJ and Silva WA Jr: COL1A1 and miR-29b show lower expression levels during osteoblast differentiation of bone marrow stromal cells from Osteogenesis Imperfecta patients. BMC Med Genet. 15:1471–2350. 2014. View Article : Google Scholar | |
Ou M, Zhang X, Dai Y, Gao J, Zhu M, Yang X, Li Y, Yang T and Ding M: Identification of potential microRNA-target pairs associated with osteopetrosis by deep sequencing, iTRAQ proteomics and bioinformatics. Eur J Hum Genet. 22:625–632. 2014. View Article : Google Scholar | |
Franceschetti T, Kessler CB, Lee SK and Delany AM: miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. J Biol Chem. 288:33347–33360. 2013. View Article : Google Scholar : PubMed/NCBI | |
Xu S, Cecilia Santini G, De Veirman K, Vande Broek I, Leleu X, De Becker A, Van Camp B, Vanderkerken K and Van Riet I: Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients. PLoS One. 8:e797522013. View Article : Google Scholar : PubMed/NCBI | |
Ell B and Kang Y: MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep. 3:5492014. View Article : Google Scholar : PubMed/NCBI | |
Zoni E and van der Pluijm G: The role of microRNAs in bone metastasis. J Bone Oncol. 5:104–108. 2016. View Article : Google Scholar : PubMed/NCBI | |
Li H, Zhang K, Liu LH, Ouyang Y, Guo HB, Zhang H, Bu J and Xiao T: MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. Oncol Lett. 10:1662–1668. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lian F, Cui Y, Zhou C, Gao K and Wu L: Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. PLoS One. 10:e01214992015. View Article : Google Scholar : PubMed/NCBI | |
Dong J, Liu Y, Liao W, Liu R, Shi P and Wang L: miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ma W, Zhang X, Chai J, Chen P, Ren P and Gong M: Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma. Tumour Biol. 35:12467–12472. 2014. View Article : Google Scholar : PubMed/NCBI | |
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun L: MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar | |
Ren X, Shen Y, Zheng S, Liu J and Jiang X: miR-21 predicts poor prognosis in patients with osteosarcoma. Br J Biomed Sci. 73:158–162. 2016. View Article : Google Scholar : PubMed/NCBI | |
Nakka M, Allen-Rhoades W, Li Y, Kelly AJ, Shen J, Taylor AM, Barkauskas DA, Yustein JT, Andrulis IL, Wunder JS, et al: Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma. Oncotarget. 27:96738–96752. 2017. | |
Keremu A, Aini A, Maimaitirexiati Y, Liang Z, Aila P, Xierela P, Tusun A, Moming H and Yusufu A: Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α. Biosci Rep. BSR20170080. 2017. View Article : Google Scholar | |
Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L and Lo Cascio V: Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 60:3356–3365. 2009. View Article : Google Scholar : PubMed/NCBI | |
Weilner S, Skalicky S, Salzer B, Keider V, Wagner M, Hildner F, Gabriel C, Dovjak P, Pietschmann P, Grillari-Voglauer R, et al: Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation. Bone. 79:43–51. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kocijan R, Muschitz C, Geiger E, Skalicky S, Baierl A, Dormann R, Plachel F, Feichtinger X, Heimel P, Fahrleitner-Pammer A, et al: Circulating microRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures. J Clin Endocrinol Metab. 101:4125–4134. 2016. View Article : Google Scholar : PubMed/NCBI | |
Li H, Wang Z, Fu Q and Zhang J: Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients. Biomarkers. 19:553–556. 2014. View Article : Google Scholar : PubMed/NCBI | |
Seeliger C, Karpinski K, Haug AT, Vester H, Schmitt A, Bauer JS and van Griensven M: Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res. 29:1718–1728. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hackl M, Heilmeier U, Weilner S and Grillari J: Circulating microRNAs as novel biomarkers for bone diseases-complex signatures for multifactorial diseases? Mol Cell Endocrinol. 432:83–95. 2016. View Article : Google Scholar | |
Yavropoulou MP, Anastasilakis AD, Makras P, Tsalikakis DG, Grammatiki M and Yovos JG: Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures. Eur J Endocrinol. 176:169–176. 2017. View Article : Google Scholar | |
Zhang X, Li Y, Chen YE, Chen J and Ma PX: Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects. Nat Commun. 7:103762016. View Article : Google Scholar : PubMed/NCBI | |
Liu J, Dang L, Li D, Liang C, He X, Wu H, Qian A, Yang Z, Au DW, Chiang MW, et al: A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts. Biomaterials. 52:148–160. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S and Dawson-Hughes B: The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 29:2520–2526. 2014. View Article : Google Scholar : PubMed/NCBI | |
Zhang J, Tu Q, Bonewald LF, He X, Stein G, Lian J and Chen J: Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res. 26:1953–1963. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sugatani T and Hruska KA: Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem. 284:4667–4678. 2009. View Article : Google Scholar : |